Responses
Respiratory infection
Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases
Compose a Response to This Article
Other responses
No responses have been published for this article.